Peptide Interactions Stabilize and Restructure Human Papillomavirus Type 16 E6 To Interact with p53

被引:42
|
作者
Ansari, Tina [1 ]
Brimer, Nicole [1 ]
Vande Pol, Scott B. [1 ]
机构
[1] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA
关键词
PROTEIN; DEGRADATION; ONCOPROTEIN; ASSOCIATION; UBIQUITINATION; BINDING; IDENTIFICATION; E6-AP; ACTIVATION; ENZYME;
D O I
10.1128/JVI.01236-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human papillomavirus type 16 (HPV-16) E6 (16E6) binds the E3 ubiquitin ligase E6AP and p53, thereby targeting degradation of p53 (M. Scheffner, B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley, Cell 63: 1129 -1136, 1990). Here we show that minimal 16E6-binding LXXLL peptides reshape 16E6 to confer p53 interaction and stabilize 16E6 in vivo but that degradation of p53 by 16E6 requires E6AP expression. These experiments establish a general mechanism for how papillomavirus E6 binding to LXXLL peptides reshapes E6 to then act as an adapter molecule.
引用
收藏
页码:11386 / 11391
页数:6
相关论文
共 50 条
  • [41] Human papillomavirus type 16 E6 induces cell competition
    Brimer, Nicole
    Vande Pol, Scott
    PLOS PATHOGENS, 2022, 18 (03)
  • [42] Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53
    Cooper, Brooke
    Brimer, Nicole
    Pol, Scott B. Vande
    JOURNAL OF VIROLOGY, 2007, 81 (22) : 12675 - 12679
  • [43] Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation
    Qian, Guoqing
    Wang, Dongsheng
    Magliocca, Kelly R.
    Hu, Zhongliang
    Nannapaneni, Sreenivas
    Kim, Sungjin
    Chen, Zhengjia
    Sun, Shi-Yong
    Shin, Dong M.
    Saba, Nabil F.
    Chen, Zhuo G.
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 21 - 32
  • [44] DNA-DAMAGE INDUCED P53 MEDIATED TRANSCRIPTION IS INHIBITED BY HUMAN PAPILLOMAVIRUS TYPE-18 E6
    GU, ZM
    PIM, D
    LABRECQUE, S
    BANKS, L
    MATLASHEWSKI, G
    ONCOGENE, 1994, 9 (02) : 629 - 633
  • [45] Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53
    Giovane, C
    Travé, G
    Briones, A
    Lutz, Y
    Wasylyk, B
    Weiss, E
    JOURNAL OF MOLECULAR RECOGNITION, 1999, 12 (02) : 141 - 152
  • [46] Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16E6
    Inoue, T
    Oka, K
    Yong-Il, H
    Vousden, KH
    Kyo, S
    Jing, P
    Hakura, A
    Yutsudo, M
    MOLECULAR CARCINOGENESIS, 1998, 21 (03) : 215 - 222
  • [47] p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development
    Zehbe, I
    Voglino, G
    Wilander, E
    Delius, H
    Marongiu, A
    Edler, L
    Klimek, F
    Andersson, S
    Tommasino, M
    CANCER RESEARCH, 2001, 61 (02) : 608 - 611
  • [48] Sonoporation Delivery of Monoclonal Antibodies against Human Papillomavirus 16 E6 Restores p53 Expression in Transformed Cervical Keratinocytes
    Togtema, Melissa
    Pichardo, Samuel
    Jackson, Robert
    Lambert, Paul F.
    Curiel, Laura
    Zehbe, Ingeborg
    PLOS ONE, 2012, 7 (11):
  • [49] Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions
    Min-Min, H.
    Ming-Rong, X.
    Ze-Yi, C.
    Kai-Xuan, Y.
    Zhi-Lin, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (06) : 2004 - 2008
  • [50] HUMAN PAPILLOMAVIRUS E6/E7 ONCOGENES AND THE P53 MEDIATED RESPONSE TO DNA-DAMAGE
    SLEBOS, RJC
    KESSIS, TD
    HEDRICK, L
    CHO, KR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 227 - 227